88 related articles for article (PubMed ID: 2479578)
1. Insertion of short hepatitis virus A amino acid sequences into poliovirus antigenic determinants results in viable progeny.
Sverdlov ED; Tsarev SA; Markova SV; Rostapshov VM; Azhikina TL; Chernov IP; Gorbalenya AE; Kolesnikova MS; Romanova LI; Teterina NL
FEBS Lett; 1989 Nov; 257(2):354-6. PubMed ID: 2479578
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and antigenicity of chimeric picornaviruses which express hepatitis A virus (HAV) peptide sequences: evidence for a neutralization domain near the amino terminus of VP1 of HAV.
Lemon SM; Barclay W; Ferguson M; Murphy P; Jing L; Burke K; Wood D; Katrak K; Sangar D; Minor PD
Virology; 1992 May; 188(1):285-95. PubMed ID: 1314456
[TBL] [Abstract][Full Text] [Related]
3. [A model of the secondary structure and distribution of antigenic determinants in the VP1 protein of hepatitis A virus].
Mesianzhinov VV
Biofizika; 1986; 31(6):961-3. PubMed ID: 2432945
[TBL] [Abstract][Full Text] [Related]
4. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.
Emini EA; Hughes JV; Perlow DS; Boger J
J Virol; 1985 Sep; 55(3):836-9. PubMed ID: 2991600
[TBL] [Abstract][Full Text] [Related]
5. Engineering poliovirus as a vaccine vector for the expression of diverse antigens.
Andino R; Silvera D; Suggett SD; Achacoso PL; Miller CJ; Baltimore D; Feinberg MB
Science; 1994 Sep; 265(5177):1448-51. PubMed ID: 8073288
[TBL] [Abstract][Full Text] [Related]
6. Conditional poliovirus mutants made by random deletion mutagenesis of infectious cDNA.
Kirkegaard K; Nelsen B
J Virol; 1990 Jan; 64(1):185-94. PubMed ID: 2152811
[TBL] [Abstract][Full Text] [Related]
7. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a hepatitis A virus strain suitable for vaccine production.
Fineschi N; Cavalieri F; Garelick H; Prugnola A; Pellegrini V; Zuckerman AJ
J Hepatol; 1991; 13 Suppl 4():S146-51. PubMed ID: 1668326
[TBL] [Abstract][Full Text] [Related]
9. Construction of recombinant DNA molecules by the use of a single stranded DNA generated by the polymerase chain reaction: its application to chimeric hepatitis A virus/poliovirus subgenomic cDNA.
Wychowski C; Emerson SU; Silver J; Feinstone SM
Nucleic Acids Res; 1990 Feb; 18(4):913-8. PubMed ID: 2156236
[TBL] [Abstract][Full Text] [Related]
10. A cassette vector for the construction of antigen chimaeras of poliovirus.
Burke KL; Evans DJ; Jenkins O; Meredith J; D'Souza ED; Almond JW
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2475-9. PubMed ID: 2476528
[TBL] [Abstract][Full Text] [Related]
11. The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity.
Harmon SA; Richards OC; Summers DF; Ehrenfeld E
J Virol; 1991 May; 65(5):2757-60. PubMed ID: 1850050
[TBL] [Abstract][Full Text] [Related]
12. Modelling of poliovirus. HIV-1 antigen chimaeras.
Crabbe MJ; Evans DJ; Almond JW
FEBS Lett; 1990 Oct; 271(1-2):194-8. PubMed ID: 1699798
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W
J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676
[TBL] [Abstract][Full Text] [Related]
14. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
[TBL] [Abstract][Full Text] [Related]
15. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
Bräutigam S; Snezhkov E; Bishop DH
Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
[TBL] [Abstract][Full Text] [Related]
16. Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles.
Delpeyroux F; Van Wezel E; Blondel B; Crainic R
J Virol; 1990 Dec; 64(12):6090-100. PubMed ID: 2173781
[TBL] [Abstract][Full Text] [Related]
17. Expression of poliovirus complementary DNA coding for viral antigenic determinants in Escherichia coli.
Kuge S; Chisaka O; Kohara M; Imura N; Matsubara K; Nomoto A
J Biochem; 1984 Aug; 96(2):305-12. PubMed ID: 6209264
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acids located in the antibody binding sites of human hepatitis A virus.
Nainan OV; Brinton MA; Margolis HS
Virology; 1992 Dec; 191(2):984-7. PubMed ID: 1280386
[TBL] [Abstract][Full Text] [Related]
19. Antigen chimaeras of poliovirus as potential new vaccines.
Burke KL; Dunn G; Ferguson M; Minor PD; Almond JW
Nature; 1988 Mar; 332(6159):81-2. PubMed ID: 2450279
[TBL] [Abstract][Full Text] [Related]
20. Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus.
Ping LH; Jansen RW; Stapleton JT; Cohen JI; Lemon SM
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8281-5. PubMed ID: 2460866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
